Market closed·Syncing…
Market closed · Close · 19 Nov

Kovai Medical Center & Hospital Limited KOVAIshare price and chart

Kovai Medical Center & Hospital closed at ₹6,459.00 on 19 November 2026, down 0.49% on the day. The range since listing is ₹5,275.50 to ₹6,750.00.

₹6,459.00The price one share last traded at, in rupees.▼ 0.49% · ₹31.80
Low since listing ₹5,27680% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹6,750

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on KOVAI

Real prices, every charge counted. Pick one or write your own.

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
63Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
59.3%Near average
today 59.3%20d avg 53.3%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.+6.8%1 monthHow much the share price has changed over the period.+11.7%3 monthsHow much the share price has changed over the period.+7.7%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.27.9%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹7,068 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.26.1xlast 4 quarters, to Sept 2026Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.23%last 12 months

Against its sectorWhere this company ranks among similar companies on each measure.

Healthcare · 213 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.26.1vs 36.24 median
Cheapest: GKB 6.05Priciest: HCG 866.06
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.15.7%vs 10.23% median
Lowest: MEDIORG -86.72%Highest: SHUKRAPHAR 38.89%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.20.57%vs 20.95% median
Lowest: NECLIFE -99.78%Highest: SHUKRAPHAR 652.15%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 11 Nov 2026), sales rose 20.6% from a year earlier to ₹473 cr and profit rose 30.8% to ₹77.0 cr.

Going well
  • No promoter shares were pledged at the end of September 2014.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Share price reaction to resultsWhat the share price did around each recent quarterly result.

Over the last 3 results, the share rose on 2 and fell on 1, and moved by 3% or more on 2.

+9%
-9%
Q4 FY26Q2 FY27

Q2 FY27: results filed 11 Nov 2026. The share went from its close on 9 Nov 2026 to its close on 12 Nov 2026 +8.69%.

Dividend historyCash the company has paid per share, year by year.

₹230 / year
Paid 4 of 6 yrs
on ₹1 lakh at today's price · 0.23% yield · ₹15/share
What each year paid, on ₹1 lakh
46
93
155
232
21
22
23
24
25
26*
* 2026 so far - more may still be declared this year

2026 has paid ₹15.00 per share, about ₹232 on ₹1 lakh at today's price. It skipped 2 of the last 6 years. Dividends are at the company's discretion and can be cut or skipped.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
+30.2%a year, over 5 years
1 yr
+150.7%
3 yr
+35.8%
5 yr
+30.2%

Held for 5 years this compounded at +30.2% a year. The last twelve months were up +150.7%. Price only, before dividends.

Backtest idea · KOVAIMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on KOVAI
Backtest idea · KOVAILower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on KOVAI
Backtest idea · KOVAISupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on KOVAI
Your own ideaWrite a rule for KOVAI in plain English“Buy KOVAI when …”
Start writing
Buy the dip on KOVAIBuy when RSI(14) drops below 30
52-week high breakout on KOVAIBuy when closes at a 52-week high
Golden cross on KOVAIBuy when 50-day EMA crosses above 200-day
Stochastic oversold on KOVAIBuy when stochastic %K drops below 20
Pullback in an uptrend on KOVAIBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹7,068 cr
Larger than 65% of 213 peers
sector middle ₹2,076 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
26.1x
Lower than 69% of 171 peers
sector middle 36.2x
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.2%
Higher than 65% of 213 peers
sector middle 0.1%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+20.6%
Around the middle of 181 peers
sector middle +20.9%

Peers are the listed companies in the exchange's own industry group: HOSPITAL. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Revenue and profit, year by yearSales and net profit by financial year or by quarter.

Sales and net profit
FY25FY26
SalesNet profitfell vs last yearEach on its own scale · hover a bar for its figures
Op. marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.27.7%FY26Profit YoYHow much net profit grew in the latest quarter against the same quarter a year earlier.+30.8%latest quarterSalesMoney earned from selling the company's goods and services, before any costs. Also called revenue.₹1,587 CrFY26Net profitWhat is left for shareholders after all costs, interest and tax.₹241 CrFY26

Where every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.

FY26

In FY26, of every ₹100 of sales it kept ₹15.2 as profit. Other income added ₹1.7.

Where it wentPer ₹100 of sales
Running costs₹72.3Depreciation₹6.9Interest₹2.0Tax₹5.4Profit₹15.2

How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.

Compounded a year
3 years5 yearsLatest qtr
Sales--+20.6%
Profit--+30.8%
3 and 5 years are compounded a year across full financial years. The latest quarter is against the same quarter a year earlier.

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY25FY26
Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.28.1%27.7%
Net marginOf every ₹100 of sales in the year, how much was left as profit after everything.15.2%15.2%
Interest coverHow many times the company's profit before interest could pay its interest bill.9.5x11.2x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · KOVAIStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on KOVAI
Backtest idea · KOVAIPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on KOVAI
Backtest idea · KOVAIBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on KOVAI
Backtest idea · KOVAI52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on KOVAI
Backtest idea · KOVAIGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on KOVAI
MACD momentum on KOVAIBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on KOVAIBuy when closes below the lower Bollinger band
Supertrend rider on KOVAIBuy when supertrend turns up
Buy the dip on KOVAIBuy when RSI(14) drops below 30
52-week high breakout on KOVAIBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Healthcare
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
SUNPHARMA
Sun Pharmaceutical Industries Limited
4.56 L cr41.6x5.1x14.7%19.1%0.0317.8%+11.9%0.84%
DIVISLAB
Divi's Laboratories Limited
2.97 L cr88.2x16.5x16.2%21.5%0.0027.6%+35.4%0.27%
TORNTPHARM
Torrent Pharmaceuticals Limited
1.75 L cr77.9x9.6x17.0%15.2%0.7612.1%+50.8%0.82%
APOLLOHOSP
Apollo Hospitals Enterprise Limited
1.26 L cr56.0x11.8x21.5%20.7%0.508.4%+20.8%0.23%
LAURUSLABS
Laurus Labs Limited
1.25 L cr92.9x20.6x17.7%17.9%0.4017.0%+33.4%0.10%
ZYDUSLIFE
Zydus Lifesciences Limited
1.20 L cr28.9x4.3x18.3%19.9%0.4414.1%+29.2%0.08%
DRREDDY
Dr. Reddy's Laboratories Limited
1.17 L cr41.7x3.0x11.5%13.9%0.158.3%-1.5%0.57%
CIPLA
Cipla Limited
1.15 L cr39.5x3.2x11.7%16.0%0.0110.1%-2.4%0.92%
MANKIND
Mankind Pharma Limited
1.09 L cr48.4x6.2x12.4%12.9%0.3014.7%+17.3%0.00%
AUROPHARMA
Aurobindo Pharma Limited
1.04 L cr26.2x2.6x9.9%12.8%0.2110.8%+23.9%0.39%
MAXHEALTH
Max Healthcare Institute Limited
1.01 L cr73.3x8.9x14.3%14.4%0.3315.1%+20.3%0.19%
MANIPALHOS
Manipal Health Enterprises Limited
91,609 cr-5.5x--0.34--0.00%
LUPIN
Lupin Limited
91,403 cr17.6x3.8x26.9%28.8%0.2317.0%+11.1%0.90%
GLENMARK
Glenmark Pharmaceuticals Limited
73,618 cr50.7x6.6x14.1%20.4%0.089.2%-31.3%0.10%
ASTERDM
Aster DM Quality Care Limited
64,443 cr102.1x8.3x10.1%14.8%0.438.7%+136.3%0.41%
ALKEM
Alkem Laboratories Limited
61,516 cr29.8x4.1x17.6%20.6%0.1213.4%+13.8%1.03%
FORTIS
Fortis Healthcare Limited
61,140 cr58.9x5.8x11.0%13.5%0.2910.7%+17.3%0.12%
BIOCON
Biocon Limited
59,264 cr216.5x1.7x1.1%3.0%0.411.9%+2.2%0.14%
ABBOTINDIA
Abbott India Limited
54,600 cr33.0x----23.0%+11.0%2.55%
GLAND
Gland Pharma Limited
54,336 cr43.9x5.1x10.5%15.0%0.0217.5%+23.3%0.61%
ANTHEM
Anthem Biosciences Limited
52,791 cr65.6x16.1x19.4%26.9%0.0130.0%+8.0%0.21%
IPCALAB
IPCA Laboratories Limited
47,189 cr33.6x5.4x13.2%16.6%0.0614.2%+13.8%0.32%
GLAXO
GlaxoSmithKline Pharmaceuticals Limited
45,967 cr40.6x24.4x48.9%66.5%0.0027.6%+20.8%2.10%
EMCURE
Emcure Pharmaceuticals Limited
44,481 cr40.7x8.3x19.6%24.8%0.2710.7%+24.3%0.15%
AJANTPHARM
Ajanta Pharma Limited
40,865 cr32.4x8.4x25.4%32.7%0.0220.3%+32.5%0.98%
MEDANTA
Global Health Limited
39,747 cr64.2x9.2x15.0%17.9%0.1612.1%+33.6%0.03%
NH
Narayana Hrudayalaya Ltd.
38,279 cr44.3x7.7x19.7%16.0%0.998.4%+73.0%0.24%
SAILIFE
Sai Life Sciences Limited
37,985 cr100.5x14.1x15.1%20.9%0.1715.9%+22.5%0.00%
WOCKPHARMA
Wockhardt Limited
35,537 cr86.7x6.9x4.0%6.5%0.3910.8%+23.9%0.00%
LALPATHLAB
Dr. Lal Path Labs Ltd.
32,952 cr56.2x12.0x21.5%29.1%0.0019.4%+19.6%0.89%
ACUTAAS
Acutaas Chemicals Limited
32,561 cr74.1x17.5x23.5%31.7%0.0027.5%+42.7%0.06%
KIMS
Krishna Institute of Medical Sciences Limited
32,248 cr147.1x8.2x9.7%9.9%0.834.3%+39.9%0.00%
PPLPHARMA
Piramal Pharma Limited
31,906 cr-3.9x-4.0%0.8%0.69-2.1%+28.1%0.00%
RUBICON
Rubicon Research Limited
28,510 cr87.3x20.1x19.1%23.4%0.2815.5%+39.9%0.09%
NEULANDLAB
Neuland Laboratories Limited
27,074 cr59.8x13.3x21.4%27.5%0.1719.6%-12.6%0.16%
APLLTD
Alembic Pharmaceuticals Limited
20,631 cr24.4x3.5x12.4%11.7%0.259.9%+36.3%1.14%
GRANULES
Granules India Limited
19,853 cr27.7x3.0x13.5%15.7%0.0912.1%+20.3%0.22%
ERIS
Eris Lifesciences Limited
18,418 cr25.8x4.4x18.1%13.9%0.5821.6%+12.6%0.54%
ONESOURCE
Onesource Specialty Pharma Limited
18,381 cr-3.1x-1.3%0.4%0.25-0.1%+37.4%0.00%
KOVAI
Kovai Medical Center & Hospital Limited
7,068 cr26.1x----15.7%+20.6%0.23%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
·
·
·
·
-5.3
+11.9
-1.5
+2.8
-1.1
-3.2
+11.1
·
+14.2%
7m
2023
+4.1
+9.9
-4.1
+6.3
+8.9
+5.0
+20.2
-0.9
-2.9
-0.7
·
·
+53.1%
10m
2022
+3.3
-12.3
+3.1
+5.0
-15.4
+3.2
+3.3
-0.9
+1.1
-0.9
+19.0
-5.5
-1.3%
2021
·
·
·
·
·
·
·
·
-3.4
-1.0
-0.7
+2.6
-2.6%
4m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

No bulk or block deals on record for KOVAI in the window we hold.

Read enough? Test KOVAI. “Buy KOVAI when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free